{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-038427","form_type":"8-K","ticker":null,"cik":"0001845459","company_name":"NKGen Biotech, Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.111126+00:00","generated_at":"2026-05-23T01:04:05.382332+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NKGen Biotech issues 2.6M shares to Kepos in warrant exercise and downside settlement","bullets":["Kepos exercised 555,555 warrants on a cashless basis, receiving 555,555 shares of NKGen common stock.","In lieu of $509,555 cash downside consideration, Kepos accepted 2,038,220 shares at $0.25/share; 2,593,775 total shares issued.","Outstanding $382,222 downside cash from prior reset to be satisfied with 1,528,888 shares at $0.25/share (future issuance).","Shares are unregistered, bear restrictive legends, and may only be transferred under Rule 144 or other registration exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-038427","json":"https://secwatch.observer/filing/0001213900-25-038427.json","markdown":"https://secwatch.observer/filing/0001213900-25-038427.md","text":"https://secwatch.observer/filing/0001213900-25-038427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/0001213900-25-038427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/ea0239780-8k_nkgen.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T01:04:05.382332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e290b545da974ddc5d4b6bf01983b12a359c8bfd","claim":"NKGen Biotech, Inc. incurred debt with Kepos Alpha Master Fund L.P..","evidence_excerpt":"the Company issued to Kepos a total of 2,593,775 shares of common stock, consisting of the Warrant Shares and the Additional Shares","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/0001213900-25-038427-index.htm","confidence":0.7,"family_label":"Debt Financings","details":[{"label":"Counterparty","value":"Kepos Alpha Master Fund L.P."},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}